Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Glucagon-like peptide-1 receptor (GLP-1) agonists are an effective treatment for controlling blood glucose levels in people with type 2 diabetes, particularly those who do not respond, or stop responding to, first-line treatments, such as There are many versions of GLP-1 drugs, including: liraglutide(Victoza), which people inject daily semaglutide (Rybelsus), an oral tablet which people take once daily dulaglutide(Trulicity), which people inject once a week semaglutide (Ozempic/ Wegovy), which people inject once a week exenatide(Bydureon), which people inject once a week
Serving Size: 1 stick (20 g)
The cost difference ($149/month starting price) reflects compounding efficiency, not reduced medication purity or efficacy
This is because diabetics are at risk of a condition called diabetic retinopathy
The most common include: Redness, tenderness, or minor swelling at the injection site Temporary fatigue or mild headache in the first week Subtle changes in appetite, sleep, or water retention depending on the peptide Serious side effects are rare when peptides are medically supervised, pharmaceutical-grade, and correctly dosed
Highly selective off-on fluorescent probe for imaging thioredoxin reductase in living cells
